Mahesh Swaminathan

Mahesh Swaminathan

M D Anderson Cancer Center University of Texas - Houston / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4959006
MD Anderson Cancer Center
person_outline Mahesh Swaminathan's MOST POPULAR ARTICLES
1-) Hematologic malignancies and Li–Fraumeni syndromeM Swaminathan, SA Bannon, M Routbort, K Naqvi, TM Kadia, ...Molecular Case Studies 5 (1), a003210, 2019632019
2-) The combination of quizartinib with azacitidine or low dose cytarabine is highly active in patients (Pts) with FLT3-ITD mutated myeloid leukemias: interim report of a phase I …M Swaminathan, HM Kantarjian, N Daver, G Borthakur, M Ohanian, ...Blood 130 (Suppl 1), 723-723, 2017622017
3-) A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndromeM Swaminathan, HM Kantarjian, M Levis, V Guerra, G Borthakur, ...Haematologica 106 (8), 2121, 2021422021
4-) Menin inhibitors in acute myeloid leukemia—what does the future hold?M Swaminathan, W Bourgeois, SA Armstrong, ES WangThe Cancer Journal 28 (1), 62-66, 2022382022
5-) Novel therapies for AML: a round-up for cliniciansM Swaminathan, ES WangExpert Review of Clinical Pharmacology 13 (12), 1389-1400, 2020382020